Načítá se...
Clinical Trials for COVID‐19: Can we Better Use the Short Window of Opportunity?
The scientific community has risen to the coronavirus disease 2019 (COVID‐19) challenge, coming up with an impressive list of candidate drugs and vaccines targeting an array of pharmacological and immunological mechanisms. Yet, generating clinical evidence of efficacy and safety of these candidate t...
Uloženo v:
| Vydáno v: | Clin Pharmacol Ther |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7272975/ https://ncbi.nlm.nih.gov/pubmed/32407539 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpt.1891 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|